⚠️ Early Stage / Preclinical Research
A viral social media claim that bee venom cures cancer has prompted patient questions. The actual research involves melittin, a peptide showing preclinical activity against cancer cells in animal and laboratory models. No human trials have occurred.
Patient Counseling Points
- Melittin is positively charged and adheres to negatively charged cancer cell membranes in preclinical models, sparing neutral healthy cells
- Animal studies showed cancer cell destruction within 6 hours of single injection, with effects persisting up to one week
- Triple-negative breast cancer cells appeared particularly susceptible in laboratory work, though findings are not validated in humans
- Researchers are exploring melittin as a drug delivery vehicle for chemotherapy, not as a standalone therapy
Patient Care Applications
- Reassure patients that bee venom is not a proven cancer treatment at any stage
- Warn against DIY bee sting exposure or unregulated venom products as actively unsafe
- Recognize the research as preclinical with no human trial data available
- Redirect interested patients toward established clinical trials for their specific cancer type
More in Social Media
PATIENT EDUCATION
OBESITY/WEIGHT MANAGEMENT
EXERCISE/TRAINING
LEGAL MATTERS
GUIDELINES/RECOMMENDATIONS